CTBench: A Comprehensive Benchmark for Evaluating Language Model Capabilities in Clinical Trial Design

Abstract: CTBench is introduced as a benchmark to assess LMs in aiding clinical study design. Given study-specific metadata, CTBench evaluates AI models' ability to determine the baseline features of a clinical trial (CT), which include demographic and relevant features collected at the trial's start from all participants. These baseline features, typically presented in CT publications (often as Table 1), are crucial for characterizing study cohorts and validating results. Baseline features, including confounders and covariates, are also necessary for accurate treatment effect estimation in studies involving observational data. CTBench consists of two datasets: "CT-Repo," containing baseline features from 1,690 clinical trials sourced from clinicaltrials.gov, and "CT-Pub," a subset of 100 trials with more comprehensive baseline features gathered from relevant publications. Two LM-based evaluation methods are developed to compare the actual baseline feature lists against LM-generated responses. "ListMatch-LM" and "ListMatch-BERT" use GPT-4o and BERT scores (at various thresholds), respectively, for evaluation. To establish baseline results, advanced prompt engineering techniques using LLaMa3-70B-Instruct and GPT-4o in zero-shot and three-shot learning settings are applied to generate potential baseline features. The performance of GPT-4o as an evaluator is validated through human-in-the-loop evaluations on the CT-Pub dataset, where clinical experts confirm matches between actual and LM-generated features. The results highlight a promising direction with significant potential for improvement, positioning CTBench as a useful tool for advancing research on AI in CT design and potentially enhancing the efficacy and robustness of CTs.